Analysis of Reportable Segments
IQVIA Holdings Inc. operates in 3 segments: Technology & Analytics Solutions; Research & Development Solutions; and Contract Sales & Medical Solutions.
Segment Profit Margin
IQVIA Holdings Inc., profit margin by reportable segment
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Technology & Analytics Solutions | 26.98% | 26.35% | 25.03% | 24.54% | 24.73% |
| Research & Development Solutions | 21.40% | 19.53% | 18.19% | 19.71% | 20.64% |
| Contract Sales & Medical Solutions | 5.65% | 9.57% | 7.69% | 6.39% | 7.28% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Technology & Analytics Solutions | Technology & Analytics Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
| Research & Development Solutions | Research & Development Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. | |
| Contract Sales & Medical Solutions | Contract Sales & Medical Solutions segment profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022. |
Segment Profit Margin: Technology & Analytics Solutions
IQVIA Holdings Inc.; Technology & Analytics Solutions; segment profit margin calculation
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Segment profit | 1,550) | 1,458) | 1,216) | 1,101) | 1,023) |
| Revenues | 5,746) | 5,534) | 4,858) | 4,486) | 4,137) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 26.98% | 26.35% | 25.03% | 24.54% | 24.73% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Segment profit margin = 100 × Segment profit ÷ Revenues
= 100 × 1,550 ÷ 5,746 = 26.98%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Technology & Analytics Solutions | Technology & Analytics Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Segment Profit Margin: Research & Development Solutions
IQVIA Holdings Inc.; Research & Development Solutions; segment profit margin calculation
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Segment profit | 1,695) | 1,476) | 1,048) | 1,141) | 1,128) |
| Revenues | 7,921) | 7,556) | 5,760) | 5,788) | 5,465) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 21.40% | 19.53% | 18.19% | 19.71% | 20.64% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Segment profit margin = 100 × Segment profit ÷ Revenues
= 100 × 1,695 ÷ 7,921 = 21.40%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Research & Development Solutions | Research & Development Solutions segment profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Segment Profit Margin: Contract Sales & Medical Solutions
IQVIA Holdings Inc.; Contract Sales & Medical Solutions; segment profit margin calculation
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Segment profit | 42) | 75) | 57) | 52) | 59) |
| Revenues | 743) | 784) | 741) | 814) | 810) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 5.65% | 9.57% | 7.69% | 6.39% | 7.28% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Segment profit margin = 100 × Segment profit ÷ Revenues
= 100 × 42 ÷ 743 = 5.65%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Contract Sales & Medical Solutions | Contract Sales & Medical Solutions segment profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022. |
Revenues
IQVIA Holdings Inc., revenues by reportable segment
US$ in millions
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Technology & Analytics Solutions | 5,746) | 5,534) | 4,858) | 4,486) | 4,137) |
| Research & Development Solutions | 7,921) | 7,556) | 5,760) | 5,788) | 5,465) |
| Contract Sales & Medical Solutions | 743) | 784) | 741) | 814) | 810) |
| Total | 14,410) | 13,874) | 11,359) | 11,088) | 10,412) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Segment profit
IQVIA Holdings Inc., segment profit by reportable segment
US$ in millions
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Technology & Analytics Solutions | 1,550) | 1,458) | 1,216) | 1,101) | 1,023) |
| Research & Development Solutions | 1,695) | 1,476) | 1,048) | 1,141) | 1,128) |
| Contract Sales & Medical Solutions | 42) | 75) | 57) | 52) | 59) |
| Total | 3,287) | 3,009) | 2,321) | 2,294) | 2,210) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).